ArticleOncoimmunology2016

Tasquinimod modulates tumor-infiltrating myeloid cells and improves the antitumor immune response to PD-L1 blockade in bladder cancer.

Jessica Nakhlé et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.